Sarah Kiely | Director, IR |
Mark Enyedy | CEO |
Anna Berkenblit | Chief Medical Officer |
Dave Johnston | CFO |
Rich Gregory | Chief Scientific Officer |
Michael Schmidt | Leerink |
Debjit Chattopadhyay | H.C. Wainwright |
Kennen MacKay | RBC |
Boris Peaker | Cowen |
Jessica Fye | JPMorgan |
Andy Hsieh | William Blair |
Biren Amin | Jefferies |
Good day and welcome everyone to the ImmunoGen Fourth Quarter 2017 and Yearend Results Conference Call. Today’s call is being recorded. And at this time, for opening remarks and introductions, I would like to turn the call over to Sarah Kiely, Investor Relations and Corporate Communications. Please go ahead.
Good morning.